Fol. Biol. 2007, 53, 97-108
https://doi.org/10.14712/fb2007053030097
Growth-inhibiting Activity of Transcription Factor C/EBPα, Its Role in Haematopoiesis and Its Tumour Suppressor or Oncogenic Properties in Leukaemias
References
1. , S., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L., Valk, P. J., Beverloo, H., Tenen, D. G., Löwenberg, B., Delwel, R. (2003) Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML. Hematol. J. 4, 31-40.
<https://doi.org/10.1038/sj.thj.6200216>
2. , G., Singh, S. M., Liu, H., Bortolin, L. T., Christopei, M., Radomska, H. S., Rangatia, J., Hiddemann, W., Friedman, A. D., Tenen, D. G. (2002) Ras signaling enhances the activity of C/EBPα to induce granulocytic differentiation by phosphorylation of serine 248. J. Biol. Chem. 277, 26293-26299.
<https://doi.org/10.1074/jbc.M202301200>
3. , E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J. I., Landschulz, W. H., McKnight, S. L. (1989) Tissue-specific expression, developmental regulation and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev. 3, 1146-1156.
<https://doi.org/10.1101/gad.3.8.1146>
4. , B. L., Darlington, G. J. (1998) C/EBPα is critical for neonatal acute-phase response to inflammation. Mol. Cell. Biol. 18, 7269-7277.
<https://doi.org/10.1128/MCB.18.12.7269>
5. , C. F., Bouwman, P. R. J., Snippe, L., Geert, A. B. (1994) Translation start site multiplicity of the CCAAT/ enhancer binding protein α mRNA is dictated by a small 5´ open reading frame. Nucleic Acids Res. 22, 5540-5547.
<https://doi.org/10.1093/nar/22.25.5540>
6. , C. F., Snippe, L., Ab, G. (1997) Differential stimulation by CCAAT/enhancer-binding protein α isoforms of the estrogen-activated promoter of the very-low-density apolipoprotein II gene. Eur. J. Biochem. 249, 113-120.
<https://doi.org/10.1111/j.1432-1033.1997.t01-2-00113.x>
7. , C. F., Muller, C., Leutz, A. (2000) Translational control of C/EBPα and C/EBPβ isoform expression. Genes Dev. 14, 1920-1932.
<https://doi.org/10.1101/gad.14.15.1920>
8. , E., Russell, L., Radford-Weiss, I., Bastard, C., Lessard, M., Struski, S., Cave, H., Fert-Ferrer, S., Barin, C., Maarek, O., Della-Valle, V., Strefford, J. C., Berger, R., Harrison, C. J., Bernard, O. A., Nguyen-Khac, F., for the Groupe Francophone de Cytogénétique Hématologique (2006) Overexpression of CEBPA resulting from the translocation t(14; 19)(q32; q13) of human precursor-B-cell acute lymphoblastic leukaemia. Blood 108, 3560-3563.
<https://doi.org/10.1182/blood-2006-03-010835>
9. , C. Z., Li, L., Lodish, H. F., Bartel, D. P. (2004) Micro RNAs modulate hematopoietic lineage differentiation. Science 303, 83-86.
<https://doi.org/10.1126/science.1091903>
10. , S.-S., Chen, J.-F., Johnson, P. F., Muppala, V., Lee, Y.-H. (2000) C/EBPβ, when expressed from the C/ebpα gene locus, can functionally replace C/EBPα in liver but not in adipose tissue. Mol. Cell. Biol. 20, 7292-7299.
<https://doi.org/10.1128/MCB.20.19.7292-7299.2000>
11. , R., Wang Q. F., Friedman A. D. (2004) C/EBPα p30, a myeloid leukemia oncoprotein, limits G-CSF receptor expression but not terminal granulopoiesis via site-selective inhibition of C/EBP DNA binding. Oncogene 23, 716-725.
<https://doi.org/10.1038/sj.onc.1207172>
12. , R., Walsh, J. C., Lancki, D., Laslo, P., Iyer, S. R., Singh, H., Simon, M. C. (2003) Regulation of macrophage and neutrophil cell fates by the PU.1: C/EBPα ratio and granulocyte colony-stimulating factor. Nat. Immunol. 4, 1029-1036.
<https://doi.org/10.1038/ni973>
13. , A., Metcalf, D., Di Rago, L., Mifsud, S., Wu, L., Nutt, S. L. (2005) PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201, 1487-1502.
<https://doi.org/10.1084/jem.20050075>
14. , F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., Bozzoni, I. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPα regulates human granulopoiesis. Cell 123, 819-831.
<https://doi.org/10.1016/j.cell.2005.09.023>
15. , P., Barlow, C., Kylefjord, H., Ährlund-Richter, L., Xanthopoulos, K. G. (1996) Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein α. J. Biol. Chem. 271, 24753-760.
<https://doi.org/10.1074/jbc.271.40.24753>
16. , S., Schlenk, R. F., Krauter, J., Thiede, C., Ehninger, G., Haase, D., Harder, L., Kreitmeier, S., Scholl, C., Caligiuri, M. A., Bloomfield, C. D., Döhner, H., Döhner, K. (2005) Acute myeloid leukemia with deletion 9q within a noncomplex karyotype is associated with CEBPA loss- of-function mutations. Genes Chromosomes Cancer 42, 427-432.
<https://doi.org/10.1002/gcc.20152>
17. , Y., Shibata, F., Miyuki, I., Goto-Koshino, Y., Sotomaru, Y., Ito, M., Kitamura, T., Nakajima, H. (2006) Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBPα. EMBO J. 25, 3398-3410.
<https://doi.org/10.1038/sj.emboj.7601199>
18. , A. F., Hofmann, W.-K., Kawano, S., Takeuchi, S., Krug, U., Kwok, S. H., Larsen, S. J., Asou, H., Miller, C. W., Hoelzer, D., Koeffler, H. P. (2002) Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias. Blood 99, 1332-1340.
<https://doi.org/10.1182/blood.V99.4.1332>
19. , C., Cowley, S. M., James, L. P., Eisenman, R. N. (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu. Rev. Cell. Dev. Biol. 16, 653-699.
<https://doi.org/10.1146/annurev.cellbio.16.1.653>
20. , O., Krauter, J., Riehle, H., Hadwiger, P., John, M., Heil, G., Vornlocher, H.-P., Nordheim, A. (2003) AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood 101, 3157-3163.
<https://doi.org/10.1182/blood-2002-05-1589>
21. , D., Mueller, B. U., Timchenko, N. A., Hagemeijer, A., Jotterand, M., Meyer-Monard, S., Lister, A., Rowley, J. D., Huegli, B., Fey, M. F., Pabst, T. (2004) The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc. Natl. Acad. Sci. USA 101, 13312-13317.
<https://doi.org/10.1073/pnas.0404731101>
22. , D., Mueller, B. U., Timchenko, N. A., Schardt, J., Eyer, M., Betts, D. R., Jotterand, M., Meyer-Monard, Fey, M. F., Pabst, T. (2005) CBFB-SMMHC is correlated with increased calreticulin expression and suppresses the granulocytic differentiation factor CEBPA in AML with inv(16). Blood 106, 1369-1375.
<https://doi.org/10.1182/blood-2004-11-4392>
23. , L. R., Darlington, G. J. (1995) Inhibition of cell proliferation by C/EBP α occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acids Res. 23, 426-433.
<https://doi.org/10.1093/nar/23.22.4726>
24. , L. R., Bachinski, L. L., Sicilliano, M. J., Fertitta, A., Trask, B., deJong, P. J., Ledbetter, D. H., Darlington, G. J. (1992) The CCAAT/enhancer binding protein (C/EBPα) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBP ß) gene (CEBPB) maps to human chromosome 20q13.1. Genomics 14, 12-17.
<https://doi.org/10.1016/S0888-7543(05)80276-9>
25. , C.-L., King-Fleischman, A. G., Lai, A. Y., Matsumoto, Y., Weissman, I. L., Kondo, M. (2006) Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors. Proc. Natl. Acad. Sci. USA 103, 672-677.
<https://doi.org/10.1073/pnas.0510304103>
26. , Y. O., Abruzzo, L. V., Rassidakis, G. Z., Parry-Jones, N., Schlette, E., Brito-Bapabulle, V., Matutes, E., Wotherspoon, A., Keating, M. J., Medeiros, J., Catovsky, D. (2007) The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br. J. Haematol. 136, 220-228.
<https://doi.org/10.1111/j.1365-2141.2006.06416.x>
27. , J., Pearce, D. (2000) A common motif within the negative regulatory regions of multiple factors inhibit their transcriptional synergy. Mol. Cell. Biol. 20, 6040-6050.
<https://doi.org/10.1128/MCB.20.16.6040-6050.2000>
28. , A., Zhang, P., Darlington, G. J., McKercher, S. R., Maki, R. A., Tenen, D. G. (1998) Use of RDA analysis of knockout mice to identify myeloid genes regulated in vivo by PU.1 and C/EBPα. Nucleic Acids Res. 26, 3034-3043.
<https://doi.org/10.1093/nar/26.12.3034>
29. , H., Mizuno, S., Arinobu, Y., Ozawa, H., Mori, Y., Shigematsu, H., Takatsu, K., Tenen, D. G., Akashi, K. (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev. 20, 3010-3021.
<https://doi.org/10.1101/gad.1493506>
30. , L. M., Iwama, A., Lodie, T. A., Sasaki, K., Felsher, D. W., Golub, T. R., Tenen D. G. (2001) c-Myc is a critical target for C/EBPα in granulopoiesis. Mol. Cell. Biol. 21, 389-3806.
<https://doi.org/10.1128/MCB.21.11.3789-3806.2001>
31. , P. F. (1993) Identification of C/EBP basic region residues involved in DNA sequence recognition and half-site spacing preference. Mol. Cell. Biol. 13, 6916-6930.
32. , P. F. (2005) Molecular stop signs: regulation of cell cycle arrest by C/EBP transcription factors. J. Cell Sci. 118, 2545-2555.
<https://doi.org/10.1242/jcs.02459>
33. , A., Krug, U., Tiesmeier, J., Aivado, M., Faulhaber, M., Stadler, M., Krauter, J., Germing, U., Hofmann, W. K., Koeffler, H. P., Ganser, A., Verbeek, W. (2003) The emergence of a C/EBPα mutation in the clonal evolution of MDS towards secondary AML. Leukemia 17, 343-349.
<https://doi.org/10.1038/sj.leu.2402805>
34. , K., Santilli, G., Corradini, F., Perrotti, D., Calabretta, B. (2003) Transcription activation function of C/EBPα is required for induction of granulocyte differentiation. Blood 102, 1267-1275.
<https://doi.org/10.1182/blood-2003-02-0477>
35. , K., He, Y., Wouters, B. J., Shestova, O., Xu, L., Sai, H., Rodriguez, C. G., Mailard, I., Tobias, J. W., Valk, P., Carrol, M., Aster, J. C., Delwel, R., Pear, W. S. (2006) Tribbles homolog 2 inactivates C/EBPα and causes acute myelogenous leukemia. Cancer Cell 10, 401-411.
<https://doi.org/10.1016/j.ccr.2006.09.012>
36. , T. K., Curran, T. (1991) Transcription factors interactions: basics on zippers. Curr. Opin. Struct. Biol. 1, 71-79.
<https://doi.org/10.1016/0959-440X(91)90014-K>
37. , T., Christoffels, V. M., Chowdhury, S., Iwase, K., Matsuzaki, H., Mori, M., Lamers, W. H., Darlington, G. J., Takiguchi, M. (1998) Hypoglycemia-associated hyperammonemia caused by impaired expression of ornithine cycle enzyme genes in C/EBPα knockout mice. J. Biol. Chem. 273, 27505-27510.
<https://doi.org/10.1074/jbc.273.42.27505>
38. , B., Suckow, M., Seydel, A., von Wilcken-Bergmann, B., Müller-Hill, B. (1995) A comparison of the different DNA binding specificities of the bZIP proteins C/EBP and GCN4. Nucleic Acids Res 23, 4162-4169.
<https://doi.org/10.1093/nar/23.20.4162>
39. , T., Friedman, A. D. (2003) Cross-talk between regulators of myeloid development: C/EBPα binds and activates the promoter of the PU.1 gene. J. Leukoc. Biol. 74, 464-470.
<https://doi.org/10.1189/jlb.1202622>
40. , J., Xanthopoulos, K. G. (1998) Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J. Biol. Chem. 273, 28545-28548.
<https://doi.org/10.1074/jbc.273.44.28545>
41. , H., Roumier, C., Huyghe, P., Biggio, V., Fenaux, P., Preudhomme, C. (2005) CEBPA point mutations in hematological malignancies. Leukemia 19, 329-334.
<https://doi.org/10.1038/sj.leu.2403614>
42. , D.-C., Shih, L.-Y., Huang, C.-F., Hung, I.-J., Yang, C. P., Liu, H. C., Jaing, T. H., Wang, L. Y., Chang, W.-H. (2005) CEBPα mutations in childhood acute myeloid leukemia. Leukemia 19, 410-414.
<https://doi.org/10.1038/sj.leu.2403608>
43. , F. T., McDougold, C. A., Diehl, A. M., Lane, M. D. (1993) A 30-kDa alternative translation product of the CCAAT/ enhancer binding protein α message: transcriptional activator lacking antimiotic activity. Proc. Natl. Acad. Sci. USA 90, 9606-9610.
<https://doi.org/10.1073/pnas.90.20.9606>
44. , H.-K., Perrier, S., Lipina, C., Finlay, D., McLauchlan, H., Hastie, C. J., Hundal, H. S., Sutherland, C. (2006) Functional characterisation of the regulation of CAAT enhancer binding protein α by GSK-3 phosphorylation of threonines 222/226. BMC Mol. Biol. 7, 14, 1-12.
<https://doi.org/10.1186/1471-2199-7-14>
45. , P. C., Whitsett, J. A., Xu, Y., Perl, A.-K. T., Wan, H., Ikegami, M. (2006) C/EBPα is required for lung maturation at birth. Development 133, 1155-1164.
<https://doi.org/10.1242/dev.02273>
46. , S. L. (2001) McBindall – a better name for CCAAT/enhancer binding proteins? Cell 107, 259-261.
<https://doi.org/10.1016/S0092-8674(01)00543-8>
47. , S. L., Lane, M. D., Gluecksohn-Waelsch, S. (1989) Is CCAAT/enhancer binding protein a central regulator of energy metabolism? Genes Dev. 3, 2021-2024.
<https://doi.org/10.1101/gad.3.12b.2021>
48. , B. U., Pabst, T. (2006) C/EBPα and the pathophysiology of acute myeloid leukemia. Curr. Opin. Hematol. 13, 7-14.
<https://doi.org/10.1097/01.moh.0000190110.08156.96>
49. , C., Alunni-Fabbroni, M., Kowenz-Leutz, E., Mo, X., Tommasino, M., Leutz, A. (1999) Separation of C/EBPα-mediated proliferation arrest and differentiation pathways. Proc. Natl. Acad. Sci. USA 96, 7276-7281.
<https://doi.org/10.1073/pnas.96.13.7276>
50. , C., Calkhoven, C. F., Sha, X., Leutz, A. (2004) The CCAAT enhancer-binding protein α (C/EBPα) requires a SWI/SNF complex for proliferation arrest. J. Biol. Chem. 279, 7353-7358.
<https://doi.org/10.1074/jbc.M312709200>
51. , C. (2004) C/EBPα mutations in acute myeloid leukaemias. Nat. Rev. Cancer 4, 394-400.
<https://doi.org/10.1038/nrc1363>
52. , C., Ziff, E. B. (1994) Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-α on the serum albumin promoter. Genes Dev. 8, 350-362.
<https://doi.org/10.1101/gad.8.3.350>
53. , C., Ziff, E. B. (1995) CCAAT/enhancer binding protein-α amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO J. 14, 4318-4328.
<https://doi.org/10.1002/j.1460-2075.1995.tb00106.x>
54. S. H. (2000) Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1, 57-64.
<https://doi.org/10.1038/35049577>
55. , V., Decombes, P., Schibler, U. (1993) CCAAT/ enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90, 8219-8223.
<https://doi.org/10.1073/pnas.90.17.8219>
56. , T., Mueller, B. U., Harakawa, N., Schoch, C., Haferlach, Behre, G., T., Hiddemann, W., Zhang, D.-E., Tenen, D. G. (2001a) AML1-ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemia. Nat. Med. 7, 444-451.
<https://doi.org/10.1038/86515>
57. , T., Mueller, B. U., Zhang, P., Radomska, H. S., Narravula, S., Schnittger, S., Behre, G., Hiddemann, W., Tenen, D. G. (2001b) Dominant negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα) in acute myeloid leukemia. Nat. Genet. 27, 263-270.
<https://doi.org/10.1038/85820>
58. , I., Cai, D. H., Wang, D., Kowalski, J., Blackford, A., Liu, H., Heckman, C. A., Gombart, A. F., Koeffler, H. P., Boxer, L. M., Friedman, A. D. (2005) CCAAT/enhancer binding protein α (C/EBPα) myeloid oncoproteins induce bcl-2 via interaction of their basic regions with nuclear factor-κB p50. Mol. Cancer Res. 3, 585-596.
<https://doi.org/10.1158/1541-7786.MCR-05-0111>
59. , T. A., Kowenz-Leutz, E., Leutz, A., Nerlov, C. (2001) Cooperation between C/EBPα, TBP/TFIIB and SWI/SNF recruiting domains is required for adipocyte differentiation. Genes Dev. 15, 3208-3216.
<https://doi.org/10.1101/gad.209901>
60. , D. O., Shih, C. H. (1991) An “attenuator domain” is sandwiched by two distinct transactivation domains in the transcription factor C/EBP. Mol. Cell. Biol. 11, 1480-1487.
61. , D., Cesi, V., Trotta, R., Guerzoni, C., Santilli, G., Campbell, K., Iervolino, A., Condorelli, F., Gambacorti-Passerini, C., caligiuri, M. A., Calabretta, B. (2002) BCR-ABL suppresses C/EBPα expression through inhibitory action of hnRNP E2. Nat. Genet. 30, 48-58.
<https://doi.org/10.1038/ng791>
62. , B. T., Pedersen, T. A., Xu, X., Lindberg, B., Wewer, U. M., Friis-Hansen, L., Nerlov, C. (2001) E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107, 247-258.
<https://doi.org/10.1016/S0092-8674(01)00516-5>
63. , B. T., Pedersen, T. A., Hasemann, M. S., Schuster, M. B., Kirstetter, P., Luedde, T., Damgaard, I., Kurz, E., Karlskov Schjerling, C., Nerlov, C. (2006) The proline-histidine-rich CDK2/CDK4 interaction region of C/EBPα is dispensable for C/EBPα-mediated growth regulation in vivo. Mol. Cell. Biol. 26, 1028-1037.
<https://doi.org/10.1128/MCB.26.3.1028-1037.2006>
64. , C., Sagot, C., Boissel, N., Cayuela, J.-M., Tigaud, I., de Botton, S., Thomas, X., Raffoux, E., Lamandin, C., Castaigne, S., Fenaux, P., Dombret, H. (2002) Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French association (ALFA). Blood 100, 2717-2723.
<https://doi.org/10.1182/blood-2002-03-0990>
65. , H. S., Basseres, D. S., Zheng, R., Zhang, P., Dayaram, T., Yamamoto, Y., Sternberg, D. W., Lokker, N., Giese, N. A., Bohlander, S. K., Schnittger, S., Delmotte M.-H., Davis, R. J., Small, D., Hiddemann, W., Gilliland, D. G., Tenen, D. G. (2006) Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations. J. Exp. Med. 203, 371-381.
<https://doi.org/10.1084/jem.20052242>
66. , D. P., Foka, P. (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561-575.
<https://doi.org/10.1042/bj20020508>
67. , H. M., Taylor, K. E., Jalali, G. R., Cheung, K. L., Harrison, C. J., Moorman, A. V. (2004) t(14;19)(q32;q13): A recurrent translocation in B-cell precursor acute lympho- blastic leukemia. Genes Chromosomes Cancer 39, 88-92.
<https://doi.org/10.1002/gcc.10299>
68. , A. G., Yang, Z., Resendes, K. K. (2005) Transcriptional regulation in myelopoiesis: Hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp. Hematol. 33, 131-143.
<https://doi.org/10.1016/j.exphem.2004.08.015>
69. , Y., Miyake, K., Kaneoka, H., Iijima, S. (2006) Sumoylation of CCAAT/enhancer-binding protein α and its functional roles in hepatocyte differentiation. J. Biol. Chem. 281, 21629-21639.
<https://doi.org/10.1074/jbc.M600852200>
70. , M. B., Porse, B. T. (2006) C/EBPα: a tumour suppressor in multiple tissues? Biochim. Biophys. Acta 1766, 88-103.
71. , G. S., Spendlove, H. E., Catovsky, D., Pritchard-Jones, K., Houlston, R. S. (2005) Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. Leukemia 19, 1276-1278.
<https://doi.org/10.1038/sj.leu.2403788>
72. , L. Y., Huang, C.-F., Lin, T.-L., Wu, J.-H., Wang, P.-N., Dunn, P., Kuo, M.-C., Tang, T.-C. (2005) Heterogeneous patterns of CEBPα mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia. Clin. Cancer Res. 11, 1821-1826.
<https://doi.org/10.1158/1078-0432.CCR-04-1932>
73. , M. H., Graf, T. (1998) A transcription factor party during blood cell differentiation. Curr. Opin. Genet. Dev. 8, 545-551.
<https://doi.org/10.1016/S0959-437X(98)80009-9>
74. , L. Y., Liang, D.-C., Huang, C.-F.,Wu, J.-H., Lin, T.-L., Wang, P.-N., Dunn, P., Kuo, M.-C., Tang, T.-C. (2006) AML patients with CEBPα mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples. Leukemia 20, 604-609.
<https://doi.org/10.1038/sj.leu.2404124>
75. , M. L., Cavenagh, J. D., Lister, T. A., Fitzgibbon, J. (2004) Mutation of CEBPA in familial acute myeloid leukemia. N. Engl. J. Med. 351, 2403-2407.
<https://doi.org/10.1056/NEJMoa041331>
76. , J., Smith, M. L., Neat, M., Cambal-Parrales, M., Dixon-McIver, A., Arch, R., Amess, J. A., Rohatiner, A. Z., Lister, T. A., Titzgibbon, J. (2003) Mutations of C/EBPα in acute myeloid leukemia FAB types M1 and M2. Genes Chromosomes Cancer 37, 72-78.
<https://doi.org/10.1002/gcc.10185>
77. , L., Benson, M. D., Iniguez-Lluhí, J. A. (2003) A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein α inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J. Biol. Chem. 278, 9134-9141.
<https://doi.org/10.1074/jbc.M210440200>
78. , K., Iyama, K. I., Kimura, T., Sano, K., Darlington, G. J., Akiba, T., Takiguchi, M. (2001) Mice lacking CCAAT/ enhancer-binding protein-α show hyperproliferation of alveolar type II cells and increased surfactant protein mRNAs. Cell Tissue Res. 306, 57-63.
<https://doi.org/10.1007/s004410100420>
79. , H. C., Goya, J., Renn, K., Friedman, A. D., Johnson, P. F., Keller, J. R. (2006) C/EBPα determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation. Blood 107, 4308-4316.
<https://doi.org/10.1182/blood-2005-06-2216>
80. , Y., Brena, R. M., Hackanson, B., Morrison, C., Otterson, G. A., Plass, C. (2006) Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein α activity in lung cancer. J. Natl. Cancer Inst. 98, 396-406.
<https://doi.org/10.1093/jnci/djj093>
81. , N., Kawamata, N., Walsh, C. S., Gery, S., Desmond, J. C., Whittaker, S., Said, J. W., Popoviciu, L. M., Jones, P. A., Miyakawa, I., Koeffler, H. P. (2005) Discovery of epigenetically masked tumor suppressor genes in endometrial cancer. Mol. Cancer Res. 3, 261-269.
<https://doi.org/10.1158/1541-7786.MCR-04-0110>
82. , D. G., Hromas, R., Licht, J. D., Zhang, D. E. (1997) Transcription factors, normal myeloid development, and leukemia. Blood 90, 489-519.
<https://doi.org/10.1182/blood.V90.2.489>
83. , N. A., Harris, T. E., Wilde, M., Bilyeu, T. A., Burgess-Beusse, B. L., Finegold, M. J., Darlington, G. J. (1997) CCAAT/enhancer-binding protein α regulates p21 protein and hepatocyte proliferation in newborn mice. Mol. Cell. Biol. 17, 7353-7361.
<https://doi.org/10.1128/MCB.17.12.7353>
84. , N. A., Wilde, M., Darlington, G. J. (1999) C/EBPα regulates formation of S-phase -specific E2F-p107 complexes in livers of newborn mice. Mol. Cell. Biol. 19, 2966-2945.
<https://doi.org/10.1128/MCB.19.4.2936>
85. , A. K., Bararia, D., Christopeit, M., Peerzada, A. A., Singh, S. M., Kieser, A., Hiddemann, W., Behre, H. M., Behre, G. (2007) Proteomic identification of C/EBP-DBD multiprotein complex: JNK1 activates stem cell regulator C/EBPα by inhibiting its ubiquitination. Oncogene 26, 1789-1801.
<https://doi.org/10.1038/sj.onc.1209964>
86. , C. R., Sigler, P. B., McKnight, S. L. (1989) Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 246, 911-916.
<https://doi.org/10.1126/science.2683088>
87. , K., Zhang, P., Rosenbauer, F., Drescher, B., Kobayashi, S., Radomska, H. S., Kutok, J. L., Gilliland, G., Krauter, J., Tenen, D. G. (2006) Absence of the transcription factor CCAAT enhancer binding protein α results in loss of myeloid identity in bcr/abl-induced malignancy. Proc. Natl. Acad. Sci. USA 103, 6338-6343.
<https://doi.org/10.1073/pnas.0508143103>
88. , D., D’Costa, J., Civin, C. I., Friedman, A. D. (2006) C/EBPα directs monocytic commitment of primary myeloid progenitors. Blood 108, 1223-1229.
<https://doi.org/10.1182/blood-2005-12-008763>
89. , G.-L., Timchenko, N. A. (2005) Dephosphorylated C/EBPα accelerates cell proliferation through sequestering retinoblastoma protein. Mol. Cell. Biol. 25, 1325-1338.
<https://doi.org/10.1128/MCB.25.4.1325-1338.2005>
90. , G.-L., Iakova, P., Wilde, M., Awad, S., Timchenko, N. A. (2004) Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBPα growth inhibitory activity. Genes Dev. 18, 912-925.
<https://doi.org/10.1101/gad.1183304>
91. , H., Iakova, P., Wilde, M., Welm, A., Goode, T., Roesler, W. J., Timchenko, N. A. (2001) C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol. Cell 8, 817-828.
<https://doi.org/10.1016/S1097-2765(01)00366-5>
92. , N. D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, R. J., Wilson, D. R., Darlington, G. J. (1995) Impaired energy homeostasis in C/EBP α knockout mice. Science 269, 1108-1112.
<https://doi.org/10.1126/science.7652557>
93. , A. A., Pulikkan, J. A., Bararia, D., Geletu, M., Trivedi, A. K., Balkhi, M. Y., Hiddemann, W. D., Tenen, D. G., Behre, H. M., Behre, G. (2006) Proteomic discovery of Max as a novel interacting partner of C/EBPα: a Myc/Max/ Mad link. Leukemia 20, 2137-2146.
<https://doi.org/10.1038/sj.leu.2404438>
94. , D. E., Zhang, P., Wang, N. D., Hetherington, C. J., Darlington, G. J., Tenen, D. G. (1997) Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94, 569-574.
<https://doi.org/10.1073/pnas.94.2.569>
95. , P., Iwama, A., Datta, M. W., Darlington, G. J., Link, D. C., Tenen, D. G. (1998) Upregulation of interleukin 6 and granulocyte colony-stimulating factor receptors by transcription factor CCAAT enhancer binding protein α (C/EBPα) is critical for granulopoiesis. J. Exp. Med. 188, 1173-1184.
<https://doi.org/10.1084/jem.188.6.1173>
96. , P., Nelson, E., Radomska, H. S., Iwasaki-Arai, J., Akashi, K., Friedman, A. D., Tenen, D. G. (2002) Induction of granulocytic differentiation by 2 pathways. Blood 99, 4406-4412.
<https://doi.org/10.1182/blood.V99.12.4406>
97. , P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., Akashi , K., Tenen, D. G. (2004) Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21, 853-863.
<https://doi.org/10.1016/j.immuni.2004.11.006>
